Euy Sung Moon

1.2k total citations
37 papers, 871 citations indexed

About

Euy Sung Moon is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Euy Sung Moon has authored 37 papers receiving a total of 871 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 23 papers in Radiology, Nuclear Medicine and Imaging and 16 papers in Surgery. Recurrent topics in Euy Sung Moon's work include Peptidase Inhibition and Analysis (31 papers), Radiopharmaceutical Chemistry and Applications (23 papers) and Cardiac Structural Anomalies and Repair (16 papers). Euy Sung Moon is often cited by papers focused on Peptidase Inhibition and Analysis (31 papers), Radiopharmaceutical Chemistry and Applications (23 papers) and Cardiac Structural Anomalies and Repair (16 papers). Euy Sung Moon collaborates with scholars based in Germany, India and Switzerland. Euy Sung Moon's co-authors include Frank Roesch, Madhav Prasad Yadav, Sanjana Ballal, Chandrasekhar Bal, Vasko Kramer, Madhavi Tripathi, Frank Rösch, Sreedharan Thankarajan Arunraj, Pieter Van der Veken and Shipra Agarwal and has published in prestigious journals such as Journal of Medicinal Chemistry, Molecules and European Journal of Medicinal Chemistry.

In The Last Decade

Euy Sung Moon

35 papers receiving 866 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Euy Sung Moon Germany 16 736 383 380 230 195 37 871
Katharina Dendl Germany 14 825 1.1× 442 1.2× 230 0.6× 444 1.9× 159 0.8× 20 946
Fabian Staudinger Germany 9 823 1.1× 473 1.2× 226 0.6× 461 2.0× 162 0.8× 12 903
Christine E. Mona United States 12 443 0.6× 171 0.4× 257 0.7× 213 0.9× 80 0.4× 25 625
Jianyang Fang China 12 383 0.5× 144 0.4× 200 0.5× 95 0.4× 106 0.5× 34 522
Zohreh Varasteh Sweden 21 610 0.8× 181 0.5× 727 1.9× 127 0.6× 87 0.4× 42 1.2k
Frank Osterkamp Germany 12 361 0.5× 112 0.3× 214 0.6× 92 0.4× 124 0.6× 21 584
Simone U. Dalm Netherlands 19 549 0.7× 50 0.1× 496 1.3× 83 0.4× 119 0.6× 42 967
Ganghua Tang China 10 242 0.3× 134 0.3× 166 0.4× 120 0.5× 51 0.3× 30 404
C R Divgi United States 10 307 0.4× 89 0.2× 247 0.7× 114 0.5× 48 0.2× 11 581
Saila Kauhanen Finland 14 468 0.6× 344 0.9× 265 0.7× 129 0.6× 12 0.1× 26 1.0k

Countries citing papers authored by Euy Sung Moon

Since Specialization
Citations

This map shows the geographic impact of Euy Sung Moon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Euy Sung Moon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Euy Sung Moon more than expected).

Fields of papers citing papers by Euy Sung Moon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Euy Sung Moon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Euy Sung Moon. The network helps show where Euy Sung Moon may publish in the future.

Co-authorship network of co-authors of Euy Sung Moon

This figure shows the co-authorship network connecting the top 25 collaborators of Euy Sung Moon. A scholar is included among the top collaborators of Euy Sung Moon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Euy Sung Moon. Euy Sung Moon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ballal, Sanjana, Chandrasekhar Bal, Tilman Läppchen, et al.. (2025). Improved FAPI-radiopharmaceutical pharmacokinetics from the perspectives of a dose escalation study. European Journal of Nuclear Medicine and Molecular Imaging. 52(9). 3238–3251. 5 indexed citations
2.
Ballal, Sanjana, Madhav Prasad Yadav, Swayamjeet Satapathy, et al.. (2025). Long-Term Outcomes in Radioiodine-Resistant Follicular Cell-Derived Thyroid Cancers Treated with [ 177 Lu]Lu-DOTAGA.FAPi Dimer Therapy. Thyroid. 35(2). 188–198. 6 indexed citations
3.
Läppchen, Tilman, Euy Sung Moon, Dariusz Pawlak, et al.. (2025). A true theranostic pair – 44/47Sc-labeled GRPR antagonist shows great promise for managing prostate and breast cancer. European Journal of Nuclear Medicine and Molecular Imaging. 53(4). 2554–2565.
4.
5.
6.
Walia, Rama, Komalpreet Kaur, Frank Roesch, et al.. (2024). Exploring the FAP-Targeted Therapeutics for Adrenocortical Carcinoma. Clinical Nuclear Medicine. 50(3). e160–e163. 1 indexed citations
7.
Roesch, Frank, Euy Sung Moon, Rama Walia, et al.. (2024). 68Ga-DOTA.SA.FAPi as a Versatile Diagnostic Probe for Various Epithelial Malignancies: A Head-to-Head Comparison with 18F-FDG. Academic Radiology. 31(6). 2521–2535. 6 indexed citations
8.
9.
Kurth, Jens, Surachet Imlimthan, Euy Sung Moon, et al.. (2023). Translational assessment of a DATA-functionalized FAP inhibitor with facile 68Ga-labeling at room temperature. European Journal of Nuclear Medicine and Molecular Imaging. 50(11). 3202–3213. 7 indexed citations
10.
Poulie, Christian B. M., Vladimir Shalgunov, Filipe Elvas, et al.. (2023). Next generation fibroblast activation protein (FAP) targeting PET tracers - The tetrazine ligation allows an easy and convenient way to 18F-labeled (4-quinolinoyl)glycyl-2-cyanopyrrolidines. European Journal of Medicinal Chemistry. 262. 115862–115862. 10 indexed citations
11.
Ballal, Sanjana, Madhav Prasad Yadav, Frank Roesch, et al.. (2023). Head-to-Head Comparison between [68Ga]Ga-DOTA.SA.FAPi and [18F]F-FDG PET/CT Imaging in Patients with Breast Cancer. Pharmaceuticals. 16(4). 521–521. 14 indexed citations
12.
Yadav, Madhav Prasad, Sanjana Ballal, Frank Roesch, et al.. (2023). Therapeutic potential of [177Lu]Lu-DOTAGA-FAPi dimers in metastatic breast cancer patients with limited treatment options: efficacy and safety assessment. European Journal of Nuclear Medicine and Molecular Imaging. 51(3). 805–819. 36 indexed citations
13.
Moon, Euy Sung, et al.. (2021). Squaric Acid-Based Radiopharmaceuticals for Tumor Imaging and Therapy. Bioconjugate Chemistry. 32(7). 1223–1231. 23 indexed citations
14.
Ballal, Sanjana, Madhav Prasad Yadav, Euy Sung Moon, et al.. (2021). First-In-Human Results on the Biodistribution, Pharmacokinetics, and Dosimetry of [177Lu]Lu-DOTA.SA.FAPi and [177Lu]Lu-DOTAGA.(SA.FAPi)2. Pharmaceuticals. 14(12). 1212–1212. 93 indexed citations
15.
Rosar, Florian, Euy Sung Moon, Frank Rösch, et al.. (2021). Impact of prompt gamma emission of 44Sc on quantification in preclinical and clinical PET systems. Applied Radiation and Isotopes. 170. 109599–109599. 6 indexed citations
16.
Ballal, Sanjana, Madhav Prasad Yadav, Vasko Kramer, et al.. (2020). A theranostic approach of [68Ga]Ga-DOTA.SA.FAPi PET/CT-guided [177Lu]Lu-DOTA.SA.FAPi radionuclide therapy in an end-stage breast cancer patient: new frontier in targeted radionuclide therapy. European Journal of Nuclear Medicine and Molecular Imaging. 48(3). 942–944. 105 indexed citations
17.
Ballal, Sanjana, Madhav Prasad Yadav, Euy Sung Moon, et al.. (2020). Biodistribution, pharmacokinetics, dosimetry of [68Ga]Ga-DOTA.SA.FAPi, and the head-to-head comparison with [18F]F-FDG PET/CT in patients with various cancers. European Journal of Nuclear Medicine and Molecular Imaging. 48(6). 1915–1931. 111 indexed citations
18.
Moon, Euy Sung, Ian Alberts, Ali Afshar‐Oromieh, et al.. (2020). Effect of the versatile bifunctional chelator AAZTA5 on the radiometal labelling properties and the in vitro performance of a gastrin releasing peptide receptor antagonist. EJNMMI Radiopharmacy and Chemistry. 5(1). 29–29. 11 indexed citations
19.
Gärtner, Florian, Milka Marinova, Ulrike Attenberger, et al.. (2020). [68Ga]Ga-DATA5m.SA.FAPi PET/CT: Specific Tracer-uptake in Focal Nodular Hyperplasia and potential Role in Liver Tumor Imaging. Nuklearmedizin - NuclearMedicine. 59(5). 387–389. 16 indexed citations
20.
Moon, Euy Sung, Filipe Elvas, Gwendolyn Vliegen, et al.. (2020). Targeting fibroblast activation protein (FAP): next generation PET radiotracers using squaramide coupled bifunctional DOTA and DATA5m chelators. EJNMMI Radiopharmacy and Chemistry. 5(1). 19–19. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katharina Dendl Breakdown of academic impact, for papers by Fabian Staudinger Breakdown of academic impact, for papers by Christine E. Mona Breakdown of academic impact, for papers by Jianyang Fang Breakdown of academic impact, for papers by Zohreh Varasteh Breakdown of academic impact, for papers by Frank Osterkamp Breakdown of academic impact, for papers by Simone U. Dalm Breakdown of academic impact, for papers by Ganghua Tang Breakdown of academic impact, for papers by C R Divgi Breakdown of academic impact, for papers by Saila Kauhanen
Rankless by CCL
2026